Following the transaction, Ceres Pharma will consolidate its foothold on the Romanian market, as part of its strategy to expand its product portfolio across Europe.
Wolf Theiss’ Corporate / M&A team in Bucharest, led by Partner Ileana Glodeanu, acted as legal advisor to Dacia Plant shareholders across all stages of the transaction, starting with the initial phase of the sale process including preparation and negotiation of the legal documentation governed by Romanian law, assistance with transactional documents and regulatory aspects, through to the signing of the transactional documents. Wolf Theiss has experience in this area, as the firm has previously advised clients on transactions in the healthcare and pharmaceuticals sectors.
Together with Partner Ileana Glodeanu, the Corporate / M&A lawyers who assisted with the deal were Senior Associates Luciana Tache and Mihai Coadă, as well as Associates Roxana Balica and Iulia Cumpăratu.
UniCredit Bank Romania, through its Investment Banking and Advisory team, coordinated by Alexandra Popa – managing director, acted as the exclusive financial consultant of the shareholders of Dacia Plant during the sale process.